H, T., J, F., J, S., Y, Y., Z, H., J, K., . . . PA, C. (2020). Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles. Nature communications, 11(1), 694. https://doi.org/10.1038/s41467-020-14340-x
Chicago Style (17th ed.) CitationH, Tsujinaka, et al. "Sustained Treatment of Retinal Vascular Diseases with Self-aggregating Sunitinib Microparticles." Nature Communications 11, no. 1 (2020): 694. https://doi.org/10.1038/s41467-020-14340-x.
MLA (9th ed.) CitationH, Tsujinaka, et al. "Sustained Treatment of Retinal Vascular Diseases with Self-aggregating Sunitinib Microparticles." Nature Communications, vol. 11, no. 1, 2020, p. 694, https://doi.org/10.1038/s41467-020-14340-x.
Warning: These citations may not always be 100% accurate.